Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-alpha-2b treatment.
Biró A, Horváth A, Varga L, Nemesánszky E, Csepregi A, Dávid K, Tolvaj G, Ibrányi E, Telegdy L, Pár A, Romics L, Karádi I, Horányi M, Gervain J, Ribiczey P, Csöndes M, Füst G.
Biró A, et al. Among authors: varga l.
Immunobiology. 2003;207(3):161-8. doi: 10.1078/0171-2985-00229.
Immunobiology. 2003.
PMID: 12777057